5th March 2015
The trend towards patients taking several medications at the same time is increasing, especially with the ageing population, giving rise to a corresponding rise in the possibility of adverse reactions.... Read more
4th March 2015
In order to attract and retain patients for a clinical trial, clinical teams should start early on planning and implementing their marketing strategies. Ken Wallace suggests the patient recruitment questions... Read more
3rd March 2015
pharmaphorum spoke to Alex Cvetkovich Muntañola about the current status of paediatric trials and the challenges that lie ahead.Could you give an overview of where paediatric clinical trials are in... Read more
2nd March 2015
More gay men in the UK are presenting to clinicians with complicated issues associated with drug use and consent to sex in ChemSex environments (taking recreational drugs during sex and... Read more
5th March 2015
UK biotech firm Summit Therapeutics is preparing a US share offer to raise funding for its research programmes.The Oxford-based company is already listed on London's AIM market, but will now... Read more
5th March 2015
Johnson & Johnson has missed out on acquiring its marketing partner Pharmacyclics after AbbVie snatched the company from under its nose with a $21 billion takeover.The acquisition of Pharmacyclics and... Read more
5th March 2015
Bristol-Myers Squibb's Opdivo has been cleared in the US to treat lung cancer, a full three months ahead of the FDA's review deadline.The positive verdict by the agency gives PD-1... Read more
4th March 2015
A filing for anti-PD-1 drug Opdivo in lung cancer, plus three new licensing and acquisition deals, shows Bristol-Myers Squibb (BMS) has no intention of slowing its immuno-oncology drive.The US FDA... Read more
Working in partnership, Atlantis Healthcare and pharmaphorum present a Tweetchat focussed on the real world challenges patients face in managing their COPD,... View more
COPD is a widespread, costly and largely preventable condition which affects over 300 million people worldwide and is recognised... View more
With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving again – what is next, what are the... View more
Now available on demand (free to access) - originally broadcast on October 29th 2014.
Non-adherence to self-management regimens in diabetes is globally... View more
How can life science brands identify winning strategic decisions when there are so many variables to consider? One route is via 'road-testing' decisions ahead of sign-off under computer game simulated... View info
With more than 80 per cent of European doctors saying they want to stay abreast of new developments about pharmaceutical products, it is important to understand how they wish to... View info
An understanding of health psychology is essential to helping patients adhere to their medication and lifestyle regimens. This report hones in on how the COM-B model of behaviour provides a... View info
Preparation is key to creating and maintaining a strong drugs pipeline. However, the statistics demonstrate that successful product commercialisation strategies are not always implemented. Products are developed for which there... View info
Patients in England and Wales look set to get access to Gilead Sciences' new hepatitis C virus (HCV) therapy Har... Read more
Sanofi's long-acting follow-up to blockbuster basal insulin Lantus has been recommended for approval in the EU, ... Read more
The $16 billion dollar 'asset swap' deal between GlaxoSmithKline (GSK) and Novartis has been formally completed ... Read more
The financial sector could provide an answer to the increasingly vexed issues of very high costs for innovative ... Read more
Bayer will need a stellar performance from its growth products this year, as it is predicting a €4 billion incre... Read more
With the annual Rare Disease Day taking place tomorrow, Caroline Mathie and Dilip Phadnis give an overview of orp... Read more
Website and content copyright © 2009-2014, pharmaphorum media limited or its licensors; all rights reserved.
The rights of trade mark owners are acknowledged.
Strategic Internet Consulting, Digital Marketing Agency
